Automation, Digitization and Robotics in Cell and Gene Therapy Manufacturing Market Size, Share, and Trends 2026 to 2035

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology 

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Automation, Digitization and Robotics in Cell and Gene Therapy Manufacturing Market 

5.1. COVID-19 Landscape: Automation, Digitization and Robotics in Cell and Gene Therapy Manufacturing Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Automation, Digitization and Robotics in Cell and Gene Therapy Manufacturing Market, By Technology Type

8.1. Automation, Digitization and Robotics in Cell and Gene Therapy Manufacturing Market, by Technology Type

8.1.1. Automated Bioprocessing Systems (Closed & Modular Systems)

8.1.1.1. Market Revenue and Forecast

8.1.2. Robotic Cell Handling & Processing Systems

8.1.2.1. Market Revenue and Forecast

8.1.3. Digital Twin & Simulation Platforms

8.1.3.1. Market Revenue and Forecast

8.1.4. AI-driven Manufacturing Execution Systems (MES)

8.1.4.1. Market Revenue and Forecast

8.1.5. Automated Quality Control & Analytics Systems

8.1.5.1. Market Revenue and Forecast

Chapter 9. Global Automation, Digitization and Robotics in Cell and Gene Therapy Manufacturing Market, By Automation Level

9.1. Automation, Digitization and Robotics in Cell and Gene Therapy Manufacturing Market, by Automation Level

9.1.1. Semi-automated Systems

9.1.1.1. Market Revenue and Forecast

9.1.2. Fully Automated Manufacturing Platforms

9.1.2.1. Market Revenue and Forecast

Chapter 10. Global Automation, Digitization and Robotics in Cell and Gene Therapy Manufacturing Market, By Application 

10.1. Automation, Digitization and Robotics in Cell and Gene Therapy Manufacturing Market, by Application

10.1.1. Cell Therapy Manufacturing (CAR-T, Stem Cell Therapy)

10.1.1.1. Market Revenue and Forecast

10.1.2. Gene Therapy Manufacturing (Viral Vectors, Non-viral Systems)

10.1.2.1. Market Revenue and Forecast

10.1.3. Process Development & Scale-up

10.1.3.1. Market Revenue and Forecast

10.1.4. Quality Control & Release Testing

10.1.4.1. Market Revenue and Forecast

10.1.5. Cold Chain & Logistics Automation

10.1.5.1. Market Revenue and Forecast

Chapter 11. Global Automation, Digitization and Robotics in Cell and Gene Therapy Manufacturing Market, By End-Use

11.1. Automation, Digitization and Robotics in Cell and Gene Therapy Manufacturing Market, by End-Use

11.1.1. Biopharmaceutical Companies

11.1.1.1. Market Revenue and Forecast

11.1.2. Contract Development and Manufacturing Organizations (CDMOs)

11.1.2.1. Market Revenue and Forecast

11.1.3. Research Institutes & Academic Centers

11.1.3.1. Market Revenue and Forecast

Chapter 12. Global Automation, Digitization and Robotics in Cell and Gene Therapy Manufacturing Market, By Deployment Type

12.1. Automation, Digitization and Robotics in Cell and Gene Therapy Manufacturing Market, by Deployment Type

12.1.1. On-premise Automation Systems

12.1.1.1. Market Revenue and Forecast

12.1.2. Cloud-based Digital Manufacturing Platforms

12.1.2.1. Market Revenue and Forecast

12.1.3. Hybrid Digital-Physical Systems

12.1.3.1. Market Revenue and Forecast

Chapter 13. Global Automation, Digitization and Robotics in Cell and Gene Therapy Manufacturing Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Technology Type

13.1.2. Market Revenue and Forecast, by Automation Level

13.1.3. Market Revenue and Forecast, by Application

13.1.4. Market Revenue and Forecast, by End-Use

13.1.5. Market Revenue and Forecast, by Deployment Type

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Technology Type

13.1.6.2. Market Revenue and Forecast, by Automation Level

13.1.6.3. Market Revenue and Forecast, by Application

13.1.6.4. Market Revenue and Forecast, by End-Use

13.1.6.5. Market Revenue and Forecast, by Deployment Type  

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Technology Type

13.1.7.2. Market Revenue and Forecast, by Automation Level

13.1.7.3. Market Revenue and Forecast, by Application

13.1.7.4. Market Revenue and Forecast, by End-Use

13.1.7.5. Market Revenue and Forecast, by Deployment Type

13.2. Europe

13.2.1. Market Revenue and Forecast, by Technology Type

13.2.2. Market Revenue and Forecast, by Automation Level

13.2.3. Market Revenue and Forecast, by Application

13.2.4. Market Revenue and Forecast, by End-Use  

13.2.5. Market Revenue and Forecast, by Deployment Type  

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Technology Type

13.2.6.2. Market Revenue and Forecast, by Automation Level

13.2.6.3. Market Revenue and Forecast, by Application

13.2.7. Market Revenue and Forecast, by End-Use  

13.2.8. Market Revenue and Forecast, by Deployment Type  

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Technology Type

13.2.9.2. Market Revenue and Forecast, by Automation Level

13.2.9.3. Market Revenue and Forecast, by Application

13.2.10. Market Revenue and Forecast, by End-Use

13.2.11. Market Revenue and Forecast, by Deployment Type

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Technology Type

13.2.12.2. Market Revenue and Forecast, by Automation Level

13.2.12.3. Market Revenue and Forecast, by Application

13.2.12.4. Market Revenue and Forecast, by End-Use

13.2.13. Market Revenue and Forecast, by Deployment Type

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Technology Type

13.2.14.2. Market Revenue and Forecast, by Automation Level

13.2.14.3. Market Revenue and Forecast, by Application

13.2.14.4. Market Revenue and Forecast, by End-Use

13.2.15. Market Revenue and Forecast, by Deployment Type

13.3. APAC

13.3.1. Market Revenue and Forecast, by Technology Type

13.3.2. Market Revenue and Forecast, by Automation Level

13.3.3. Market Revenue and Forecast, by Application

13.3.4. Market Revenue and Forecast, by End-Use

13.3.5. Market Revenue and Forecast, by Deployment Type

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Technology Type

13.3.6.2. Market Revenue and Forecast, by Automation Level

13.3.6.3. Market Revenue and Forecast, by Application

13.3.6.4. Market Revenue and Forecast, by End-Use

13.3.7. Market Revenue and Forecast, by Deployment Type

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Technology Type

13.3.8.2. Market Revenue and Forecast, by Automation Level

13.3.8.3. Market Revenue and Forecast, by Application

13.3.8.4. Market Revenue and Forecast, by End-Use

13.3.9. Market Revenue and Forecast, by Deployment Type

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Technology Type

13.3.10.2. Market Revenue and Forecast, by Automation Level

13.3.10.3. Market Revenue and Forecast, by Application

13.3.10.4. Market Revenue and Forecast, by End-Use

13.3.10.5. Market Revenue and Forecast, by Deployment Type

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Technology Type

13.3.11.2. Market Revenue and Forecast, by Automation Level

13.3.11.3. Market Revenue and Forecast, by Application

13.3.11.4. Market Revenue and Forecast, by End-Use

13.3.11.5. Market Revenue and Forecast, by Deployment Type

13.4. MEA

13.4.1. Market Revenue and Forecast, by Technology Type

13.4.2. Market Revenue and Forecast, by Automation Level

13.4.3. Market Revenue and Forecast, by Application

13.4.4. Market Revenue and Forecast, by End-Use

13.4.5. Market Revenue and Forecast, by Deployment Type

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Technology Type

13.4.6.2. Market Revenue and Forecast, by Automation Level

13.4.6.3. Market Revenue and Forecast, by Application

13.4.6.4. Market Revenue and Forecast, by End-Use

13.4.7. Market Revenue and Forecast, by Deployment Type

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Technology Type

13.4.8.2. Market Revenue and Forecast, by Automation Level

13.4.8.3. Market Revenue and Forecast, by Application

13.4.8.4. Market Revenue and Forecast, by End-Use

13.4.9. Market Revenue and Forecast, by Deployment Type

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Technology Type

13.4.10.2. Market Revenue and Forecast, by Automation Level

13.4.10.3. Market Revenue and Forecast, by Application

13.4.10.4. Market Revenue and Forecast, by End-Use

13.4.10.5. Market Revenue and Forecast, by Deployment Type

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Technology Type

13.4.11.2. Market Revenue and Forecast, by Automation Level

13.4.11.3. Market Revenue and Forecast, by Application

13.4.11.4. Market Revenue and Forecast, by End-Use

13.4.11.5. Market Revenue and Forecast, by Deployment Type

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Technology Type

13.5.2. Market Revenue and Forecast, by Automation Level

13.5.3. Market Revenue and Forecast, by Application

13.5.4. Market Revenue and Forecast, by End-Use

13.5.5. Market Revenue and Forecast, by Deployment Type

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Technology Type

13.5.6.2. Market Revenue and Forecast, by Automation Level

13.5.6.3. Market Revenue and Forecast, by Application

13.5.6.4. Market Revenue and Forecast, by End-Use

13.5.7. Market Revenue and Forecast, by Deployment Type

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Technology Type

13.5.8.2. Market Revenue and Forecast, by Automation Level

13.5.8.3. Market Revenue and Forecast, by Application

13.5.8.4. Market Revenue and Forecast, by End-Use

13.5.8.5. Market Revenue and Forecast, by Deployment Type

Chapter 14. Company Profiles

14.1. Thermo Fisher Scientific Inc. 

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Sartorius AG

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Danaher Corporation (Cytiva)

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Lonza Group AG

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Merck KGaA

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Fujifilm Diosynth Biotechnologies

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. GE HealthCare Technologies Inc.

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Siemens AG

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. ABB Ltd.

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Universal Robots A/S

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms